Natera reported after the close of market Tuesday year-over-year revenue gains of approximately 26 percent for the fourth quarter of 2022 and 31 percent for the full year.

Roche’s third-quarter results have revealed a clear sign that the bumper sales boosting companies that have provided products to diagnose, treat or prevent COVID-19 since the start of the pandemic are starting to tail off.

Recently, the localization project of QIAGEN has received another good news. The automatic nucleic acid extraction instrument QIAcube HT has been received the first-class medical device filing approval

Hologic reported after the close of the market on Wednesday that declining sales of COVID-19 assays and difficulties obtaining semiconductor chips contributed to an overall 14 percent year-over-year decline in its fiscal third quarter revenues.

Recently, Wondfo Biotech received the confirmation letter of in vitro diagnostic pre-qualification (PQ) issued by the World Health Organization (WHO). Recommended purchase list.

ASMS Product Launches: Thermo Fisher, Bruker, Waters, Shimadzu, Newomics

Quidel on Thursday said that it expects its first quarter revenues to nearly triple year over year, primarily on sales of COVID-19 testing products.

Jiangsu Mole Bioscience obtained the approval of the Helicobacter pylori 23S rRNA gene and gyrA gene mutation test kit (fluorescence PCR method) by NMPA. This kit is the first product in China that can simultaneously detect clarithromycin and levofloxacin resistance genes.

Thermo Fisher Scientific held the unveiling ceremony of the first domestic gas chromatography-mass spectrometry in Suzhou factory. Runda announced that the new generation of clinical mass spectrometer - ARP-6465md triple quadrupole mass spectrometer system has been released.

As the 4th China International Import Expo (CIIE) was about to be launched, CACLP, one of the family members of GL events, and the unique medical expo on IVD industry, sincerely invites you to visit our booth with No. of 8.2A2-07!